Concert Pharmaceuticals, Inc.
METHODS OF TREATMENT WITH DEUTERATED ANALOGS OF D-SERINE

Last updated:

Abstract:

This disclosure relates to deuterated D-serine, pharmaceutically acceptable salts thereof, analogs and prodrugs thereof, pharmaceutical compositions thereof, and methods of use.

Status:
Application
Type:

Utility

Filling date:

29 May 2020

Issue date:

14 Jul 2022